TABLE 2.
Comparison of sociodemographic, clinical and pharmacological variables with types of dementia in a group of patients in Colombia, 2019.
| Variables | Alzheimer’s disease | Unspecified dementias | Vascular dementia | Dementia in Parkinson’s disease | Other dementias | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n = 8,711 | % | n = 1767 | % | n = 657 | % | n = 201 | % | n = 36 | % | |
| Woman | 5,945 | 68.2 | 1,151 | 65.1 | 375 | 57.1 | 87 | 43.3 | 15 | 41.7 |
| Age (mean; SD) | 80.7 ± 9.5 | 80.5 ± 10.1 | 80.9 ± 9.7 | 77.7 ± 9.5 | 68.4 ± 9.6 | |||||
| Geographic regions | – | – | – | – | – | – | – | – | – | – |
| Pacific region | 2045 | 23.2 | 599 | 33.9 | 299 | 45.5 | 75 | 37.3 | 11 | 30.6 |
| Bogotá-cundinamarca region | 2,304 | 26.4 | 523 | 29.6 | 110 | 16.7 | 34 | 16.9 | 11 | 30.6 |
| The caribbean region | 2,332 | 26.8 | 297 | 16.8 | 83 | 12.6 | 36 | 17.9 | 10 | 27.8 |
| Central region | 1,591 | 18.3 | 298 | 16.9 | 145 | 22.1 | 46 | 22.9 | 1 | 2.8 |
| Eastern region | 444 | 5.1 | 46 | 2.6 | 17 | 2.6 | 9 | 4.5 | 3 | 8.3 |
| Amazon region-orinoquía | 15 | 0.2 | 4 | 0.2 | 3 | 0.5 | 1 | 0.5 | 0 | 0.0 |
| With chronic comorbidities | 6,748 | 77.5 | 1,349 | 76.3 | 559 | 85.1 | 170 | 84.6 | 27 | 75.0 |
| 1 pathology | 2,914 | 33.5 | 595 | 33.7 | 232 | 35.3 | 52 | 24.9 | 12 | 33.3 |
| 2 pathologies | 2,132 | 24.5 | 426 | 24.1 | 175 | 23.1 | 70 | 34.8 | 9 | 25.0 |
| ≥3 pathologies | 1702 | 19.5 | 328 | 18.6 | 152 | 23.1 | 48 | 23.9 | 6 | 16.7 |
| Cardiovascular pathologies | 3,998 | 45.9 | 776 | 43.9 | 314 | 47.8 | 71 | 35.3 | 10 | 27.8 |
| Psychiatric pathologies | 2013 | 23.1 | 407 | 23.0 | 155 | 23.6 | 56 | 27.9 | 13 | 36.1 |
| Endocrine pathologies | 1924 | 22.1 | 365 | 20.7 | 147 | 22.4 | 30 | 14.9 | 4 | 11.1 |
| Urological pathologies | 1,533 | 17.6 | 285 | 16.1 | 159 | 24.2 | 47 | 23.4 | 5 | 13.9 |
| Neurological pathologies | 696 | 8.0 | 170 | 9.6 | 95 | 14.5 | 91 | 45.3 | 7 | 19.4 |
| Use of antidementiants | 6,571 | 75.4 | 897 | 50.8 | 314 | 47.8 | 50 | 24.9 | 9 | 25.0 |
| Rivastigmine | 3,917 | 45.0 | 686 | 38.8 | 192 | 29.2 | 42 | 20.9 | 6 | 16.7 |
| Memantine | 3,372 | 38.7 | 238 | 13.5 | 134 | 20.4 | 8 | 4.0 | 4 | 11.1 |
| Donepezil | 146 | 1.7 | 13 | 0.7 | 5 | 0.8 | 0 | 0.0 | 0 | 0.0 |
| Galantamine | 134 | 1.5 | 21 | 1.2 | 8 | 1.2 | 1 | 0.5 | 0 | 0.0 |
| Use of antipsychotics | 3,139 | 36.0 | 712 | 40.3 | 279 | 42.5 | 70 | 34.8 | 22 | 61.1 |
| Atypical | 2,680 | 30.8 | 537 | 30.4 | 226 | 34.4 | 66 | 32.8 | 17 | 47.2 |
| Quetiapine | 2031 | 23.3 | 416 | 23.5 | 178 | 27.1 | 49 | 24.4 | 12 | 33.3 |
| Risperidone | 447 | 5.1 | 52 | 2.9 | 18.0 | 2.7 | 6 | 3.0 | 2 | 5.6 |
| Clozapine | 217 | 2.5 | 61 | 3.5 | 21 | 3.2 | 10 | 5.0 | 3 | 8.3 |
| Typical | 705 | 8.1 | 232 | 13.1 | 74 | 11.3 | 5 | 2.5 | 7 | 19.4 |
| Levomepromazine | 427 | 4.9 | 127 | 7.2 | 37 | 5.6 | 5 | 2.5 | 4 | 11.1 |
| Haloperidol | 314 | 3.6 | 129 | 7.3 | 42 | 6.4 | 1 | 0.5 | 3 | 8.3 |
| Pipothiazine | 4 | 0.0 | 2 | 0.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
| Comedications | – | – | – | – | – | – | – | – | – | – |
| Antihypertensives and diuretics | 5,267 | 60.5 | 1,078 | 61.0 | 439 | 66.8 | 103 | 51.2 | 15 | 41.7 |
| Antidepressants | 3,922 | 45.0 | 851 | 48.2 | 321 | 48.9 | 88 | 43.8 | 16 | 44.4 |
| Non-opioid pain relievers | 2,786 | 32.0 | 593 | 33.6 | 228 | 34.7 | 77 | 38.3 | 12 | 33.3 |
| Antiulcer | 2,517 | 28.9 | 572 | 32.4 | 214 | 32.6 | 67 | 33.3 | 14 | 38.9 |
| Platelet antiaggregants | 2,353 | 27.0 | 472 | 26.7 | 250 | 38.1 | 44 | 21.9 | 6 | 16.7 |
*Other dementias: Includes dementia in Huntington’s disease, frontotemporal dementia, and dementia in human immunodeficiency virus infection.